VUNO Partners with European Firms to Advance DeepCARS Market Entry in Europe

Published: Wednesday, October 29, 2025 at 1:14 am

VUNO Partners with European Firms to Expand AI-Powered Cardiac Arrest Prediction

SEOUL, South Korea – VUNO Inc., a global medical AI company, has announced a strategic partnership to bring its AI-based cardiac arrest prediction solution, VUNO Med-DeepCARS, to the European market. The company signed a Memorandum of Understanding (MOU) with Contextflow, an Austrian imaging AI company, and Mesalvo, a German hospital information system provider.

The agreement, finalized on October 27, aims to facilitate DeepCARS' entry into the European healthcare landscape. The collaboration will focus on technical integration, real-world validation, and reimbursement strategies to support the adoption of DeepCARS across European hospitals.

Contextflow will contribute its expertise in reimbursement and regulatory processes for imaging AI solutions, aiding DeepCARS in navigating regulatory compliance and market access. Mesalvo will integrate DeepCARS into its electronic health record (EHR) systems and data platforms. This integration could potentially allow DeepCARS to reach over 900 hospitals across Europe.

DeepCARS is an AI-powered medical device designed to predict the risk of in-hospital cardiac arrest within the next 24 hours. It analyzes patients' vital signs, including blood pressure, heart rate, respiratory rate, and body temperature. The solution has already been implemented across more than 50,000 hospital beds in South Korea. DeepCARS received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in 2023 and is currently undergoing the FDA approval process.

VUNO showcased DeepCARS at a dedicated booth at the 38th Annual Congress of the European Society of Intensive Care Medicine (ESICM LIVES 2025). The company highlighted the solution's features and predictive performance.

BNN's Perspective: This partnership represents a promising step towards leveraging AI to improve patient care in Europe. While the integration of AI in healthcare raises important ethical and data privacy considerations, the potential to improve patient outcomes and streamline clinical workflows is undeniable. Careful consideration of regulatory frameworks and data security will be crucial for the successful implementation of DeepCARS across the continent.

Keywords: VUNO, DeepCARS, AI, cardiac arrest, Europe, Contextflow, Mesalvo, medical device, healthcare, MOU, hospital, EHR, prediction, ESICM, FDA, AI in healthcare

Full Story